Dual mTOR inhibitor MLN0128 suppresses Merkel cell carcinoma (MCC) xenograft tumor growth

Merkel cell carcinoma (MCC) is an aggressive neuroendocrine skin cancer. Pathologic activation of PI3K/mTOR pathway and elevated expression of c-Myc are frequently detected in MCC. Yet, there is no targeted therapy presently available for this lethal disease. Recently, MLN0128, a second-generation d...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Kannan, Aarthi, Lin, Zhenyu, Shao, Qiang, Zhao, Stephanie, Fang, Bin, Moreno, Mauricio A., Vural, Emre, Stack, Brendan C., Suen, James Y., Kannan, Krishnaswamy, Gao, Ling
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2015
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4872734/
https://ncbi.nlm.nih.gov/pubmed/26536665
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.5878
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars